Jasper Therapeutics, Inc. (JSPRW) › Shareholders' EquityJasper Therapeutics, Inc. (JSPRW) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$4.73M2020: -$35.13M2021: $69.52M2022: $35.99M2023: $78.44M2024: $61.67M2025: $4.15M$4.15M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$4.15M-93.3%2024$61.67M-21.4%2023$78.44M+118.0%2022$35.99M-48.2%2021$69.52M+297.9%2020-$35.13M-642.1%2019-$4.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share